Civic Intelligence

Autoimmune Registry Inc.

990 • Fiscal year 2016 • EIN 81-1688265

Jan 01, 2016 to Dec 31, 2016

Guilford, CT
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Liabilities / Revenue

55th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Net Margin

65th percentile

11%

Higher net margin than 65% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2016

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2016

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2016

Assets

$1,830

No earlier filing loaded for comparison.

Net Assets

$1,830

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$17,100

No earlier filing loaded for comparison.

Expenses

$15,270

No earlier filing loaded for comparison.

Net Income

$1,830

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$20K$10K$0-$10KAssets 2016: $1,830Liabilities 2016: $0Net Assets 2016: $1,8302016Assets 2017: $1,604Liabilities 2017: $283Net Assets 2017: $1,3212017Assets 2018: $2,549Liabilities 2018: $531Net Assets 2018: $2,0182018Assets 2019: $4,115Liabilities 2019: $63Net Assets 2019: $4,1152019Assets 2020: $5,021Liabilities 2020: $191Net Assets 2020: $4,8302020Assets 2021: $12,351Liabilities 2021: $5,498Net Assets 2021: $6,8532021Assets 2022: $4,540Liabilities 2022: $6,534Net Assets 2022: -$1,9942022Assets 2023: $18,357Liabilities 2023: $2,944Net Assets 2023: $15,4132023Assets 2024: $18,687Liabilities 2024: $8,746Net Assets 2024: $9,9412024

Highlighted filing

2016

Assets$1,830
Liabilities$0
Net Assets$1,830

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$80K$60K$40K$20K$0-$20KRevenue 2016: $17,100Expenses 2016: $15,270Net Income 2016: $1,8302016Revenue 2017: $17,156Expenses 2017: $17,382Net Income 2017: -$2262017Revenue 2018: $8,705Expenses 2018: $8,008Net Income 2018: $6972018Revenue 2019: $2,973Expenses 2019: $939Net Income 2019: $2,0342019Revenue 2020: $5,942Expenses 2020: $5,123Net Income 2020: $8192020Revenue 2021: $18,769Expenses 2021: $16,798Net Income 2021: $1,9712021Revenue 2022: $13,379Expenses 2022: $22,226Net Income 2022: -$8,8472022Revenue 2023: $70,136Expenses 2023: $52,728Net Income 2023: $17,4082023Revenue 2024: $58,563Expenses 2024: $64,036Net Income 2024: -$5,4732024

Highlighted filing

2016

Revenue$17,100
Expenses$15,270
Net Income$1,830
Filing Detail Status

This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Mission and Program Overview

Mission

Autoimmune Registry, Inc., ARI, is a 501(c)(3) non-profit umbrella organization that provides a hub for research, statistics, and patient data on all autoimmune diseases. ARI operates a database where patients who suffer from any autoimmune disease can enroll to participate in medical research and clinical trials. Our goals are: 1. To reduce the time of diagnosis, 2. To support research, 3. To research, compute and publish statistics on all autoimmune diseases, 4. To serve as a trusted source of credible, scientifically supported information about every autoimmune disease, including diseases currently suspected of being autoimmune, and 5. To Increase awareness of autoimmune diseases to ensure they receive the attention and funding they deserve.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings